Unique ID issued by UMIN | UMIN000017078 |
---|---|
Receipt number | R000019450 |
Scientific Title | Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives. |
Date of disclosure of the study information | 2015/04/10 |
Last modified on | 2016/11/29 14:31:08 |
Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.
Gastric ESD on thienopyridines study.
Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.
Gastric ESD on thienopyridines study.
Japan |
Gastric neoplasms
Gastroenterology | Cardiology |
Malignancy
NO
We aimed to evaluate safety of gastric ESD without discontinuation of thienopyridine derivatives.
Safety
Post operative bleeding rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Endoscopic submucosal dissection
20 | years-old | <= |
85 | years-old | > |
Male and Female
1) Diagnosed as or suspicious of gastric adenoma/adenocarcinoma (cStageIA).
2) More than six months after last PCI.
3) An oral administration of clopidogrel or prasugrel.
4) A treatment for a single lesion.
5) Older than 19 years and younger than 85 years.
6) Performance status of 0-2.
7) Normal liver, renal, and hematological functions.
8) Follow-up of 60 days after treatment.
9) Written informed consent.
1) Double registration.
2) A past history of coronary stent embolism.
3) A stent located in left main coronary trunk.
4) A past history of irradiation in upper abdomen.
5) A plan of following treatment for esophageal or duodenal lesions.
6) A recent treatment for upper GI lesions within 28 days before registration.
7) A plan of following treatment for upper GI lesions within 28 days after treatment.
8) A systemic administration of steroids or anticoagulants.
9) An administration of NSAID or other antiplatelets that can be withdrawn before treatment.
10) Pregnancy or bleastfeeding.
11) An active bacterial or fungal infection.
12) A poor control of hypertension.
13) A severe respiratory disease.
14) Other conditions that are judged not suitable.
10
1st name | |
Middle name | |
Last name | Satoshi Ono |
The University of Tokyo
Department of Gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo.
03-3815-5411
satoshi-tky@umin.ac.jp
1st name | |
Middle name | |
Last name | Satoshi Ono |
The University of Tokyo
Department of Gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo.
03-3815-5411
satoshi-tky@umin.ac.jp
The University of Tokyo
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
NO
2015 | Year | 04 | Month | 10 | Day |
Unpublished
Completed
2015 | Year | 02 | Month | 26 | Day |
2015 | Year | 04 | Month | 10 | Day |
2016 | Year | 11 | Month | 28 | Day |
2016 | Year | 11 | Month | 28 | Day |
2016 | Year | 11 | Month | 28 | Day |
2016 | Year | 12 | Month | 31 | Day |
2015 | Year | 04 | Month | 08 | Day |
2016 | Year | 11 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019450